Navigation Links
Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
Date:9/29/2008

peak to doctors about off-label uses of the three drugs. The company funded continuing medical education programs, through millions of dollars in grants, to promote off-label uses of its drugs, in violation of the FDA's requirements.

In a plea agreement with the United States, Cephalon agreed to pay $50 million to resolve this Information, of which $40 million will be applied to a criminal fine, and $10 million will be applied as substitute assets to satisfy the forfeiture obligation.

In a separate civil settlement executed contemporaneously with this guilty plea agreement, Cephalon will pay $375 million, plus interest, to resolve False Claims Act allegations arising from claims to Medicaid, Medicare and other federal programs, including TRICARE, the Federal Employees Health Benefits program, the Postal Worker's Compensation Program, the Federal Employees Compensation Act Program, the Every Employees Occupational Illness Compensation Program, Department of Veterans Affairs, Defense Logistics Agency, Bureau of Prisons and the Public Health Service Entities. The state Medicaid programs of California, Delaware, Florida, Hawaii, Illinois, Louisiana, Massachusetts, Nevada, New Hampshire, New Mexico, Texas, Tennessee, Virginia and the District of Columbia will share $116 million of the civil settlement.

"This settlement is further evidence of the Department's willingness to prosecute cases involving violations of the FDCA and to recover taxpayer dollars used to pay for drugs sold as a result of illegal marketing campaigns," said Gregory G. Katsas, Assistant Attorney General for the Justice Department's Civil Division. "The Department takes off-label marketing of drugs very seriously because of the potential for patient harm arising from promoting drugs for uses not approved by the FDA."

The civil settlement resolves four qui tam actions filed in the Eastern District of Pennsylvania. Three of those cases were filed by former Cephalon sales repre
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
2. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
3. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
5. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
6. Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah
7. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
8. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
9. Tela Sourcing, Inc., an Adaptis Company, Acquires HealthASPex Business
10. Nevada company, ORNL develop potential lifesaver
11. ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Fourroux Prosthetics, located at 6630 McGinnis Ferry Rd, ... opening with a ribbon cutting ceremony on Wednesday, June ... kind in the area, Fourroux Prosthetics will provide amputee ... use of patented advanced prosthetics CAD/CAM technology. ... states, “Our goal has always been to provide amputees ...
(Date:6/3/2015)... “ Scanalytics ” was featured on ... features the latest and coolest technology products available to ... of NewsWatch, conducted the review and shared with viewers ... in retail stores. , Tracking statistics in business is ... comes to retail this goes a step beyond revenue ...
(Date:6/3/2015)... Consulting Services is excited to announce their achievement in ... April 2006, they have made it a priority to ... every year they have worked diligently in surpassing this ... they are off to a great start already for ... is the Customer Review site veatchconsultingreviews.weebly.com. At this site ...
(Date:6/2/2015)... June 02, 2015 Allred Dental, a dental ... for the months June-September, 2015 along with a $100 off ... limited time only. , “Sometimes wisdom teeth can be impacted, ... jawbone. They can also only partially break through the gum, ... recovery is easier in young people, as they do not ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Food Lion ... its sixth annual “Thriller on the Griller” events, starting ... and South Carolina locations. Each event will raise funds ... to restoring a sense of self, restoring the family ... our military families. , Through these events, Food ...
Breaking Medicine News(10 mins):Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3Health News:$100 Off Coupon for Wisdom Teeth Extractions Offered at Allred Dental 2Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 2Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 3
... Inc. (OTC Bulletin Board: SGTI) ("Shengtai" or "the ... grade,glucose products in China, today commented on a ... total of 850 billion RMB (USD 123 billion) ... the next three years,the multi-billion health care plan ...
... susceptibility, study says , , THURSDAY, Feb. 5 (HealthDay News) -- ... variant may affect a person,s risk of multiple sclerosis, according ... D deficiency while in the womb and early in life ... Both genetic and environmental factors play a role in MS, ...
... technology and cardiovascular diseaseHOUSTON, Feb. 5 "I salute ... No. 1 killer - cardiovascular diseases, including stroke. ... served as a clinical scientist and flight surgeon, I ... benefit medical and health care fields -- notably through ...
... 5 According to the Better Sleep,Council,s relationship expert ... help improve their relationship by catching extra,winks together in ... they,can,t sleep well side by side. , ... our mind and body, gives us energy,and improves our ...
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer ... announced today that the Australian Therapeutic Goods,Administration (TGA) ... Aortic Bioprosthesis. The Company looks forward to ... care for the Australian market. , ...
... spray when it was launched on the web in 2004. Now Sinus ... more than 5,000 Rite Aid drug stores. , ... Parsippany, NJ (PRWEB) February 5, 2009 ... pepper nasal spray in 2004 with a handful of sales on eBay. By ...
Cached Medicine News:Health News:Shengtai Pharmaceutical, Inc. Comments on China's Recently Approved Health Care Reform Plan 2Health News:Shengtai Pharmaceutical, Inc. Comments on China's Recently Approved Health Care Reform Plan 3Health News:Vitamin D Deficit May Trigger MS Risk Gene 2Health News:Coalition for Space Exploration Salutes American Heart Month 2Health News:Wake Up Your Relationship With a Good Night in Bed This Valentine's Day 2Health News:Wake Up Your Relationship With a Good Night in Bed This Valentine's Day 3Health News:Wake Up Your Relationship With a Good Night in Bed This Valentine's Day 4Health News:ATS Medical Announces Australian Regulatory Approval for ATS 3f Aortic Bioprosthesis 2Health News:ATS Medical Announces Australian Regulatory Approval for ATS 3f Aortic Bioprosthesis 3Health News:Sinus Buster Pepper Nasal Spray Moves Into Rite Aid Drug Stores 2
(Date:6/3/2015)...  (AHIP Institute Booth 1021) --  Availity , the ... a wide range of information to help health plans ... Health Insurance Plan,s (AHIP,s) 2015 Institute , June 3-5, ... Availity released a special report to AHIP Institute ... opportunities." The report identifies billions of dollars ...
(Date:6/3/2015)... MARLBOROUGH, Mass. , June 3, 2015 ... RXII ), a biotechnology company focused on ... the areas of dermatology and ophthalmology, today announced ... from the United States Patent and Trademark ... platform (sd‑rxRNA®). The patent, titled "RNA Interference ...
(Date:6/3/2015)... 3, 2015  EIP Pharma LLC ( www.eippharma.com ) ... development of VX-745 in Alzheimer,s disease (AD) is underway.  ... potent inhibitor of the alpha isoform of the protein ... "Recent human genetic data demonstrate that inflammation ... symptomatic Alzheimer,s, while the science also indicates the p38 ...
Breaking Medicine Technology:Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 2Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 3RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 2RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 3RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 4EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 3
... InfuSystem Holdings, Inc. (NYSE MKT: INFU) ("InfuSystem" or ... related services, today announced that it received a letter ... Amex of the "record date" for the 2012 Annual ... the record date for the Company,s 2012 Annual Meeting, ...
... (NASDAQ: ROCM ) is pleased to announce an addition ... of the Magic3 Hydrophilic Intermittent Catheter with Coude Tip ... very latest Magic3 technology. It provides the ... designed curved tip configuration. The Coude tip is ...
Cached Medicine Technology:InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders 2Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter 2
4 mm x 9 mm tip....
Large. Double-ended. 3 mm pointed end and 5 mm angled end....
4 mm wide tip....
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Medicine Products: